Danaher (NYSE:DHR) updated its fourth quarter 2018 earnings guidance on Thursday. The company provided earnings per share guidance of $1.25-1.28 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.28. Danaher also updated its FY 2018 guidance to $4.49-4.52 EPS.
A number of brokerages have recently commented on DHR. Robert W. Baird dropped their target price on Danaher from $116.00 to $114.00 and set an outperform rating for the company in a report on Friday. Zacks Investment Research cut Danaher from a hold rating to a sell rating in a report on Monday, July 16th. Royal Bank of Canada lifted their target price on Danaher to $107.00 and gave the stock a positive rating in a report on Thursday, July 19th. They noted that the move was a valuation call. ValuEngine upgraded Danaher from a hold rating to a buy rating in a report on Thursday, July 12th. Finally, Morgan Stanley lifted their target price on Danaher from $120.00 to $122.00 and gave the stock an overweight rating in a report on Friday, July 20th. One equities research analyst has rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Danaher has an average rating of Buy and a consensus target price of $112.14.
DHR opened at $100.39 on Friday. Danaher has a 52-week low of $90.05 and a 52-week high of $110.13. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.50 and a quick ratio of 1.07. The firm has a market cap of $70.84 billion, a P/E ratio of 24.91, a price-to-earnings-growth ratio of 1.95 and a beta of 1.01.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 26th. Investors of record on Friday, September 28th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date is Thursday, September 27th. Danaher’s payout ratio is currently 15.88%.
In related news, EVP William K. Daniel sold 103,086 shares of the business’s stock in a transaction on Friday, August 10th. The stock was sold at an average price of $100.63, for a total transaction of $10,373,544.18. Following the completion of the transaction, the executive vice president now owns 167,080 shares in the company, valued at approximately $16,813,260.40. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Robert S. Lutz sold 14,555 shares of the business’s stock in a transaction on Tuesday, July 24th. The shares were sold at an average price of $103.93, for a total value of $1,512,701.15. Following the transaction, the senior vice president now owns 18,044 shares of the company’s stock, valued at approximately $1,875,312.92. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 299,961 shares of company stock valued at $30,619,691. 11.90% of the stock is owned by company insiders.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Recommended Story: Price to Earnings Ratio (PE) Basics
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.